[SLRX] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
18-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -2.97%
YoY- 6.11%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 0 571 1,269 1,479 1,378 1,243 1,133 -
PBT -3,737 -3,074 -1,852 -1,768 -1,717 -1,784 -2,084 47.54%
Tax -10 -42 47 10 -42 62 -286 -89.28%
NP -3,737 -3,074 -1,852 -1,768 -1,717 -1,784 -2,084 47.54%
Tax Rate - - - - - - - -
Total Cost 3,737 3,646 3,121 3,246 3,095 3,028 3,217 10.49%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 0.00 -538.05 -145.95 -119.52 -124.55 -143.51 -183.95 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -2.09 -1.72 -1.52 -2.84 -2.39 -3.20 -5.46 -47.24%
EPS Diluted -2.09 -1.72 -1.52 -2.84 -2.39 -3.20 -5.46 -47.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.